Article

Identification of Protor as a novel Rictor-binding component of mTOR complex-2

MRC Protein Phosphorylation Unit, School of Life Sciences, MSI/WTB Complex, University of Dundee, Dundee DD1 5EH, Scotland, UK. ).
Biochemical Journal (Impact Factor: 4.4). 09/2007; 405(3):513-22. DOI: 10.1042/BJ20070540
Source: PubMed

ABSTRACT

The mTOR (mammalian target of rapamycin) protein kinase is an important regulator of cell growth. Two complexes of mTOR have been identified: complex 1, consisting of mTOR-Raptor (regulatory associated protein of mTOR)-mLST8 (termed mTORC1), and complex 2, comprising mTOR-Rictor (rapamycininsensitive companion of mTOR)-mLST8-Sin1 (termed mTORC2). mTORC1 phosphorylates the p70 ribosomal S6K (S6 kinase) at its hydrophobic motif (Thr389), whereas mTORC2 phosphorylates PKB (protein kinase B) at its hydrophobic motif (Ser473). In the present study, we report that widely expressed isoforms of unstudied proteins termed Protor-1 (protein observed with Rictor-1) and Protor-2 interact with Rictor and are components of mTORC2. We demonstrate that immunoprecipitation of Protor-1 or Protor-2 results in the co-immunoprecipitation of other mTORC2 subunits, but not Raptor, a specific component of mTORC1. We show that detergents such as Triton X-100 or n-octylglucoside dissociate mTOR and mLST8 from a complex of Protor-1, Sin1 and Rictor. We also provide evidence that Rictor regulates the expression of Protor-1, and that Protor-1 is not required for the assembly of other mTORC2 subunits into a complex. Protor-1 is a novel Rictor-binding subunit of mTORC2, but further work is required to establish its role.

Download full-text

Full-text

Available from: Adel Ibrahim
    • "echnology has identifi ed mTORC1 activity throughout the cytoplasm and nucleus (Zhou et al . 2015). mTORC2 is defi ned by the interaction of mTOR with Rictor and mLST8/GβL (Sarbassov et al . 2004), but much like mTORC1, additional regulatory interacting proteins have been identifi ed. These include DEPTOR, mSin1 and Protor 1/2 (Frias et al . 2006 ;Pearce et al . 2007 ;Peterson et al . 2009). mTORC2 has primarily been characterized as a downstream effector of the insulin/IGF-1 signaling pathway , and several of its substrates have been characterized. This includes three distinct sites on AKT that are important for its activation—AKT T450, the turn-motif, AKT S473, the hydrophobic motif, and AKT S477/47"
    [Show abstract] [Hide abstract]
    ABSTRACT: Lipids are essential for many cellular and organismal processes, yet an excess of lipids can cause toxicity. The liver is a key organ for the maintenance of lipid homeostasis, performing lipogenesis as well as mediating the exchange of lipoproteins with peripheral tissues. In this chapter, we focus primarily on the regulation of lipogenesis in the liver by the protein kinase mTOR (mechanistic Target of Rapamycin), a central sensor of environmental cues that coordinates growth, protein synthesis and metabolism with nutrient availability. The mTOR protein kinase is found in two distinct complexes, each of which plays a role in the regulation of lipogenesis. We discuss the regulation of lipogenesis both directly by hepatic mTOR, indirectly by mTOR in other organs, and the regulation of hepatic lipogenesis by hormones and growth factors that regulate mTOR. This regulation by mTOR is an extremely complex process that we are only now beginning to fully understand.
    No preview · Chapter · Jan 2016
  • Source
    • "In addition to the mTOR catalytic subunit, both complexes contain: Deptor, an inhibitor of mTOR [23], mLST8 (also known as GbL) [24] [25], and the Tti1/ Tel2 complex [26], two structural proteins. Pras40, also an mTOR inhibitor, and Raptor are exclusive to mTORC1 [27] [28] [29] [30] [31] [32], whereas Rictor, mSin1 and Protor1/2 are mTORC2- specific components [28] [33] [34]. Importantly, both complexes are susceptible to such mTOR inhibitors as Rapamycin or Torin [35] [36]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Over the last few years extensive studies have linked the activity of mTORC1 to lysosomal function. These observations propose an intriguing integration of cellular catabolism, sustained by lysosomes, with anabolic processes, largely controlled by mTORC1. Interestingly, lysosomal function directly affects mTORC1 activity and is regulated by ZKSCAN3 and TFEB, two transcription factors and substrates of mTORC1. Thus, the lysosomal mTOR signaling complex represents a hub of cellular energy metabolism, and its dysregulation may lead to a number of human diseases. Here, we discuss the recent developments and highlight the open questions in this growing field.
    Full-text · Article · Jan 2015 · Journal of Cell Death
  • Source
    • "Raptor is essential to mTORC1 activity. The mTORC2 complex includes the rapamycin-insensitive companion of mTOR (Rictor), mammalian stress-activated MAP kinase-interacting protein 1 (mSIN1), and proteins observed with rictor 1 and 2 (PROTOR 1 and 2) (Jacinto et al., 2004, 2006; Pearce et al., 2007; Sarbassov et al., 2004) (Figure 1B). Rictor and mSIN1 are both critical to mTORC2 function. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The mechanistic target of rapamycin (mTOR) signaling pathway is a crucial cellular signaling hub that, like the nervous system itself, integrates internal and external cues to elicit critical outputs including growth control, protein synthesis, gene expression, and metabolic balance. The importance of mTOR signaling to brain function is underscored by the myriad disorders in which mTOR pathway dysfunction is implicated, such as autism, epilepsy, and neurodegenerative disorders. Pharmacological manipulation of mTOR signaling holds therapeutic promise and has entered clinical trials for several disorders. Here, we review the functions of mTOR signaling in the normal and pathological brain, highlighting ongoing efforts to translate our understanding of cellular physiology into direct medical benefit for neurological disorders.
    Full-text · Article · Oct 2014 · Neuron
Show more